Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Idiotypic antibody immunotherapy of cancer.

× No keyword cloud information.

48 in total

Review 1. Revised immune network concepts.

Authors: H Köhler; T Kieber-Emmons; S Srinivasan; S Kaveri; W J Morrow; S Müller; C Y Kang; S Raychaudhuri
Journal: Clin Immunol Immunopathol Date: 1989-07

2. Human tumor antigens.

Authors: R A Reisfeld; D A Cheresh
Journal: Adv Immunol Date: 1987 Impact factor: 3.543

3. Idiotypic networks and their possible exploitation for manipulation of the immune response.

Authors: I M Roitt; A Cooke; D K Male; F C Hay; G Guarnotta; P M Lydyard; L P de Carvalho; Y Thanavala; J Ivanyi
Journal: Lancet Date: 1981-05-09 Impact factor: 79.321

4. Sendai virus-specific T-cell clones: induction of cytolytic T cells by an anti-idiotypic antibody directed against a helper T-cell clone.

Authors: H C Ertl; R W Finberg
Journal: Proc Natl Acad Sci U S A Date: 1984-05 Impact factor: 11.205

5. Towards a network theory of the immune system.

Authors: N K Jerne
Journal: Ann Immunol (Paris) Date: 1974-01

6. Murine monoclonal anti-idiotype antibody as a potential network antigen for human carcinoembryonic antigen.

Authors: M Bhattacharya-Chatterjee; S Mukerjee; W Biddle; K A Foon; H Köhler
Journal: J Immunol Date: 1990-10-15 Impact factor: 5.422

7. Tumor idiotype vaccines. VII. Analysis and correlation of structural, idiotypic, and biologic properties of protective and nonprotective Ab2.

Authors: S Raychaudhuri; C Y Kang; S V Kaveri; T Kieber-Emmons; H Köhler
Journal: J Immunol Date: 1990-07-15 Impact factor: 5.422

8. Antimetastatic vaccination of tumor-bearing mice with two types of IFN-gamma gene-inserted tumor cells.

Authors: A Porgador; R Bannerji; Y Watanabe; M Feldman; E Gilboa; L Eisenbach
Journal: J Immunol Date: 1993-02-15 Impact factor: 5.422

9. Monoclonal antibody SN2 defining a human T cell leukemia-associated cell surface glycoprotein.

Authors: B K Seon; S Negoro; M P Barcos; C K Tebbi; D Chervinsky; T Fukukawa
Journal: J Immunol Date: 1984-04 Impact factor: 5.422

10. Idiotype vaccines against human T cell leukemia. II. Generation and characterization of a monoclonal idiotype cascade (Ab1, Ab2, and Ab3).

Authors: M Bhattacharya-Chatterjee; S K Chatterjee; S Vasile; B K Seon; H Kohler
Journal: J Immunol Date: 1988-08-15 Impact factor: 5.422

3 in total

1. Anti-GD2 Strategy in the Treatment of Neuroblastoma.

Authors: Richard K Yang; Paul M Sondel
Journal: Drugs Future Date: 2010 Impact factor: 0.148

2. Dose-dependent access of murine anti-epidermal growth factor receptor monoclonal antibody to tumor cells in patients with advanced laryngeal and hypopharyngeal carcinoma.

Authors: H Bier; K A Reiffen; I Haas; P Stasiecki
Journal: Eur Arch Otorhinolaryngol Date: 1995 Impact factor: 2.503

Review 3. Anti-GD2 Directed Immunotherapy for High-Risk and Metastatic Neuroblastoma.

Authors: Godfrey Chi-Fung Chan; Carol Matias Chan
Journal: Biomolecules Date: 2022-02-24

3 in total